nr |
titel |
auteur |
tijdschrift |
jaar |
jaarg. |
afl. |
pagina('s) |
type |
1 |
Advisory Board and Contents
|
|
|
|
11 |
6 |
p. i-ii |
artikel |
2 |
Cancer associated to low-penetrance TP53 variants: insights from p.R337H
|
Lalli, Enzo |
|
|
11 |
6 |
p. 499-502 |
artikel |
3 |
Compromised epigenetic robustness in cancer: fueling evolution, exposing weakness
|
Wilson, Thomas Stuart |
|
|
11 |
6 |
p. 575-590 |
artikel |
4 |
Mixing it up: boosting responses with immunotherapy combinations
|
Komatsuda, Hiroki |
|
|
11 |
6 |
p. 496-498 |
artikel |
5 |
Molecular and clinical insights into early-onset endometrial cancer
|
Wu, Zimeng |
|
|
11 |
6 |
p. 503-519 |
artikel |
6 |
Myeloid cell path to malignancy: insights into liver cancer
|
Ramirez, Christel F.A. |
|
|
11 |
6 |
p. 591-610 |
artikel |
7 |
Novel metabolic routes to cancer immune evasion
|
Jaa, Ayoub |
|
|
11 |
6 |
p. 493-495 |
artikel |
8 |
Protease regulation of tumor-immune cell symbiosis
|
Pang, Lizhi |
|
|
11 |
6 |
p. 560-574 |
artikel |
9 |
Subscription & copyright page
|
|
|
|
11 |
6 |
p. e1 |
artikel |
10 |
Targeting GPX4 palmitoylation to boost antitumor immunity
|
Hwang, Daehee |
|
|
11 |
6 |
p. 491-492 |
artikel |
11 |
Targeting novel immune checkpoints in the B7-H family: advancing cancer immunotherapy from bench to bedside
|
Luo, Yiming |
|
|
11 |
6 |
p. 540-559 |
artikel |
12 |
The clinical landscape of CAR-engineered unconventional T cells
|
Li, Yan-Ruide |
|
|
11 |
6 |
p. 520-539 |
artikel |